Cargando…
Anti-infection mechanism of phosphodiesterase-5 inhibitors and their roles in coronavirus disease 2019 (Review)
Coronavirus disease 2019 (COVID-19) has a variety of impacts on the human body. Severe acute respiratory syndrome coronavirus 2 is the pathogen that causes COVID-19. It invades human tissues through the receptor angiotensin-converting enzyme 2, resulting in an imbalance in the angiotensin II (AngII)...
Autores principales: | Su, Hao, Ma, Chengquan, Li, Hongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903479/ https://www.ncbi.nlm.nih.gov/pubmed/33732293 http://dx.doi.org/10.3892/etm.2021.9751 |
Ejemplares similares
-
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis
por: Ma, Chengquan, et al.
Publicado: (2020) -
The role of phosphodiesterase-5 inhibitors in prostatic inflammation: a review
por: Peixoto, Christina Alves, et al.
Publicado: (2015) -
Evolution of Phosphodiesterase-5 Inhibitors
por: Moon, Du Geon
Publicado: (2015) -
The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma
por: Ma, Chengquan, et al.
Publicado: (2021) -
Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants
por: Tiwari, Amit K., et al.
Publicado: (2013)